• Northwest Bio Seeks GMP Certification of Sawston Mfg. Facility contractpharma
    May 13, 2021
    Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, applied for certification of the manufacturing facility in Sawston, UK with the Medicines and Healthcare Products Regulatory ...
  • Northwest Biotherapeutics Acquires Flaskworks americanpharmaceuticalreview
    September 03, 2020
    Northwest Biotherapeutics announced the Company has acquired Flaskworks, a company that has developed a system to close and automate the manufacturing of cell therapy products such as DCVax®.
  • NW Bio Accelerating Sawston Plant Phase I Buildout contractpharma
    September 02, 2020
    Construction crews working double shifts to accelerate completion despite COVID effects.
PharmaSources Customer Service